| Entry |
|
|---|
| Name |
Apraclonidine hydrochloride (JAN/USP);
Iopidine (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C9H10Cl2N4. HCl
|
|---|
| Exact mass |
280.0049
|
|---|
| Mol weight |
281.5694
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
|
|---|
| Remark |
| Therapeutic category: | 1319 |
| Product (DG01130): | D01008<JP/US> |
|
|---|
| Efficacy |
Antihypertensive (intraocular), alpha2-Adrenergic receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EA Sympathomimetics in glaucoma therapy
S01EA03 Apraclonidine
D01008 Apraclonidine hydrochloride (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Intraocular Pressure Lowering Agents
Alpha-adrenergic Agonists, Ophthalmic
Apraclonidine
D01008 Apraclonidine hydrochloride (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D01008 Apraclonidine hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG01130 Apraclonidine
D01008 Apraclonidine hydrochloride
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG01130 Apraclonidine
D01008 Apraclonidine hydrochloride
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D01008 Apraclonidine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2
D01008 Apraclonidine hydrochloride (JAN/USP) <JP/US>
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG01130 Apraclonidine
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG01130 Apraclonidine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 16
1 X Cl 21.4656 -17.6574
2 C8x C 12.8100 -16.9400
3 C8y C 12.8100 -18.3400
4 C8x C 14.0000 -19.0400
5 C8y C 15.2600 -18.3400
6 C8y C 15.2600 -16.9400
7 C8y C 14.0000 -16.2400
8 X Cl 16.4500 -19.0400
9 N2x N 17.6400 -18.3400
10 C2y C 17.6400 -16.9400
11 N1b N 16.4500 -16.2400
12 C1x C 18.9700 -18.7600
13 C1x C 19.8100 -17.6400
14 N1x N 18.9700 -16.5200
15 X Cl 14.0000 -14.8400
16 N1a N 11.5947 -19.0351
BOND 16
1 2 3 2
2 3 4 1
3 4 5 2
4 5 6 1
5 6 7 2
6 2 7 1
7 5 8 1
8 9 10 2
9 10 11 1
10 6 11 1
11 9 12 1
12 12 13 1
13 13 14 1
14 10 14 1
15 7 15 1
16 3 16 1
|
|---|
